Iterum Therapeutics plc (ITRM) Financial Statements (2024 and earlier)

Company Profile

Business Address FITZWILLIAM COURT, 1ST FLOOR
DUBLIN 2, D02 YW24
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments23,93060,80481,34414,5084,80184,551
Cash and cash equivalents6,07121,09227,44614,5084,80144,551
Short-term investments17,85939,71253,898  40,000
Restricted cash and investments    603030
Receivables 383953656475317
Prepaid expense5616346806466191,359
Deferred costs     2,339 
Other undisclosed current assets1,0676118776,1943,8546,714
Total current assets:25,59662,44483,26621,47211,71892,971
Noncurrent Assets
Property, plant and equipment516991421572700
Intangible assets, net (including goodwill)  1,7193,435   
Intangible assets, net (excluding goodwill)  1,7193,435   
Restricted cash and investments3434642486090
Other noncurrent assets5782,5674,65310,65113,4014,110
Total noncurrent assets:6634,3898,24311,32014,0334,900
TOTAL ASSETS:26,25966,83391,50932,79225,75197,871
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities12,7577,1202,2642,74728,14411,200
Taxes payable221102200113
Accounts payable4,9962,77487881615,4864,041
Accrued liabilities7,7614,3461,1651,82912,4587,046
Debt  1,6276,3745,8001,019
Derivative instruments and hedges, liabilities  1966,05828,865  
Other liabilities7611,7482,9923,5983,042 
Other undisclosed current liabilities   114  
Total current liabilities:13,5189,06412,94141,69836,98612,219
Noncurrent Liabilities
Long-term debt and lease obligation 11,45310,09410,36627,6347,62513,079
Long-term debt, excluding current maturities 11,45310,0946,93022,4627,62513,079
Liabilities, other than long-term debt3762,6083,4365,8027,378951
Other liabilities1881,3043,4365,8027,378951
Operating lease, liability1881,3043,4365,172 
Other undisclosed noncurrent liabilities7,31517,06814,5328,217  
Total noncurrent liabilities:19,14429,77028,33441,65315,00314,030
Total liabilities:32,66238,83441,27583,35151,98926,249
Equity
Equity, attributable to parent(6,403)27,99950,234(50,559)(26,238)71,622
Common stock1351261,827494149144
Additional paid in capital454,759451,150426,900235,876208,536203,271
Accumulated other comprehensive income (loss) 1(350)    
Accumulated deficit(461,298)(422,927)(378,493)(286,929)(234,923)(131,793)
Total equity:(6,403)27,99950,234(50,559)(26,238)71,622
TOTAL LIABILITIES AND EQUITY:26,25966,83391,50932,79225,75197,871

Income Statement (P&L) ($ in thousands)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues     37869
Gross profit:     37869
Operating expenses(47,468)(30,383)(24,537)(32,126)(102,058)(77,428)
Operating loss:(47,468)(30,383)(24,537)(32,126)(102,021)(76,559)
Nonoperating income (expense)9,710(13,750)(66,322)(19,137)(665)(25)
Other nonoperating income82503195213196401
Interest and debt expense    340  
Other undisclosed loss from continuing operations before equity method investments, income taxes    (340)  
Loss from continuing operations before income taxes:(37,758)(44,133)(90,859)(51,263)(102,686)(76,584)
Income tax expense(613)(301)(705)(743)(444)(472)
Loss from continuing operations:(38,371)(44,434)(91,564)(52,006)(103,130)(77,056)
Loss before gain (loss) on sale of properties:(91,564)(52,006)(103,130)(77,056)
Net loss available to common stockholders, diluted:(38,371)(44,434)(91,564)(52,006)(103,130)(77,056)

Comprehensive Income ($ in thousands)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(38,371)(44,434)(91,564)(52,006)(103,130)(77,056)
Comprehensive loss:(38,371)(44,434)(91,564)(52,006)(103,130)(77,056)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent351(350)    
Comprehensive loss, net of tax, attributable to parent:(38,020)(44,784)(91,564)(52,006)(103,130)(77,056)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: